Crowdonomics
WatchlistPortfolio
All companies

Carolina Complete Health Network, Inc.

Operating

Fintech · Raleigh, NC

Estimated pre-money ⓘ
$1.1M
As of Feb 2018 · from Reg A Offering (2018) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$1,128,750
Crowd $0 · Private $1.1M · 2 rounds since 2018
Latest share price
$750.00
Reg A Offering (2018) offering price

Financials

FY2016–FY2018 · from SEC filings · hover any figure for its source
$300K
−$1.4M
2016
$300K
−$2.0M
2017
$300K
−$1.4M
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016 audited
FY2017 audited
FY2018 audited
Income statement
Revenue
$300,000
$300,000
$300,000
Cost of goods sold
$607,510
—
—
Gross margin
-103%
—
—
Net income
-$1,353,010
-$2,018,520
-$1,353,010
Balance sheet
Cash
$1
$1,009,613
$1,210,388
Accounts receivable
$0
$52,016
$25,000
Total assets
$1
$1,070,174
$1,248,377
Long-term debt
$1,171,060
—
—
Total liabilities
$1,662,317
$2,358,167
$4,625,617
Other
Headcount
0
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$1.1M
est. pre-money
Reg A+ · Equity · Feb 2018

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Apr 30, 2019
Class P Common Stock · 50.0%Common stock · 50.0%
ClassOutstandingVotes / shareShare of totalLast price
Class P Common Stock1,505—50.0%—
Common stock(as of Jun 30, 2018)1,505—50.0%—
Total3,010100%

Shares outstanding over timein today's share terms

3K2K0
Feb 2018Oct 2018
Class P Common StockCommon stock

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · Feb 2018Failed
Raised $0 / $15MEst. pre-money $1.1M
Rule 506(b) · Equity · Jan 2018Closed
Raised $1.1MInvestors 28

Team

6 people
Jeffrey W. Runge, MD
Director, President and Chief Executive Officer
Vincent T. Morgus, MBA, CPA
Chief Operating Officer
Stephen W. Keene, MBA, JD, LLM
Secretary-Treasurer
John Jacob Meier IV, MD, MBA
Director
John R. Mangum, MD
Director
Richard Hudspeth, MD
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

SEC filings

View all 25 filings on EDGAR
  • Form 1-ZMar 23, 20200001213900-20-007097
    EDGAR
  • Form 1-UFeb 5, 20200001213900-20-002668
    EDGAR
  • Form 1-SASep 18, 20190001213900-19-018337
    EDGAR
  • Form 1-A POSApr 30, 20190001213900-19-007421
    EDGAR
  • Form 253G2Apr 30, 20190001213900-19-007417
    EDGAR
  • Form 1-KApr 30, 20190001213900-19-007413
    EDGAR
  • Form 1-UApr 24, 20190001213900-19-007021
    EDGAR
  • Form 253G2Mar 20, 20190001213900-19-004526
    EDGAR
Source: SEC EDGARCIK 0001715363DEShare price $750.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.